Incidental papillary microcarcinoma of the thyroid--factors affecting lymph node metastasis
- PMID: 17690905
- DOI: 10.1007/s00423-007-0213-2
Incidental papillary microcarcinoma of the thyroid--factors affecting lymph node metastasis
Abstract
Background and aims: Despite the overall excellent prognosis for patients with thyroid papillary microcarcinoma (PMC), these tumors are associated with lymph node metastasis. The aim of this study is to identify the rate of lymph node metastasis and evaluate the clinical and pathological factors affecting metastasis in thyroid PMC.
Methods: Among 475 patients with papillary thyroid carcinoma treated between 1990 and 2003, 81 patients (17%) were diagnosed as PMC and the records of these patients were evaluated retrospectively. Clinicopathologic features were evaluated by univariate and multivariate analyses.
Results: According to age, metastases, extent, and size risk definition, all patients were in low-risk group. Lymph node metastases were determined in 12.3% of patients. Mean follow-up was 7 years (range from 28 to 192 months). Ten-year disease-free and overall survival rates were 97 and 100%, respectively. Both multifocality and thyroid capsular invasion were found to be independent risk factors for lymph node metastasis by multivariate analysis.
Conclusion: Patients with thyroid PMC in low-risk group with multifocal tumors and with capsule invasion may have increased risk of lymph node metastasis, and must be considered in follow-up of the patients who have these factors.
Similar articles
-
Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.Thyroid. 2009 Jul;19(7):707-16. doi: 10.1089/thy.2008.0270. Thyroid. 2009. PMID: 19348581
-
Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.Thyroid. 2010 Feb;20(2):147-52. doi: 10.1089/thy.2008.0243. Thyroid. 2010. PMID: 19785522
-
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.Minerva Endocrinol. 2013 Sep;38(3):269-79. Minerva Endocrinol. 2013. PMID: 24126547
-
[Indication and extent of cervical lymph node dissection in differentiated thyroid carcinoma].Zentralbl Chir. 2011 Aug;136(4):364-73. doi: 10.1055/s-0030-1247462. Epub 2010 Aug 13. Zentralbl Chir. 2011. PMID: 20711956 Review. German.
-
Macrofollicular variant of papillary thyroid carcinoma with extensive lymph node metastases.Endocr Pathol. 2014 Sep;25(3):265-72. doi: 10.1007/s12022-014-9306-y. Endocr Pathol. 2014. PMID: 24671758 Review.
Cited by
-
Prognostic factors in differentiated thyroid cancer--a 20-year surgical outcome study.Langenbecks Arch Surg. 2012 Jun;397(5):809-15. doi: 10.1007/s00423-011-0899-z. Epub 2012 Feb 15. Langenbecks Arch Surg. 2012. PMID: 22350610 Free PMC article.
-
The Effect of Thyroid-Stimulating Hormone on Tumor Size in Differentiated Thyroid Carcinoma.Indian J Surg. 2015 Dec;77(Suppl 3):967-70. doi: 10.1007/s12262-014-1084-8. Epub 2014 May 5. Indian J Surg. 2015. PMID: 27011492 Free PMC article.
-
The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.World J Surg. 2016 Jan;40(1):100-9. doi: 10.1007/s00268-015-3346-4. World J Surg. 2016. PMID: 26578322
-
The Utility of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma with Occult Lymph Nodes.PLoS One. 2015 Jun 5;10(6):e0129304. doi: 10.1371/journal.pone.0129304. eCollection 2015. PLoS One. 2015. PMID: 26046782 Free PMC article.
-
Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.Oncol Lett. 2015 Oct;10(4):2559-2564. doi: 10.3892/ol.2015.3544. Epub 2015 Jul 29. Oncol Lett. 2015. PMID: 26622889 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical